BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3305946)

  • 1. New inhibitors of human renin that contain novel Leu-Val replacements.
    Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
    J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
    Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
    J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
    Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
    J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New inhibitors of renin that contain novel phosphostatine Leu-Val replacements.
    Dellaria JF; Maki RG; Stein HH; Cohen J; Whittern D; Marsh K; Hoffman DJ; Plattner JJ; Perun TJ
    J Med Chem; 1990 Feb; 33(2):534-42. PubMed ID: 2105396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
    Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
    J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin inhibitory peptides.
    Thaisrivongs S; Schostarez HJ; Pals DT; Turner SR
    J Med Chem; 1987 Oct; 30(10):1837-42. PubMed ID: 3309315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
    Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.
    Plattner JJ; Greer J; Fung AK; Stein H; Kleinert HD; Sham HL; Smital JR; Perun TJ
    Biochem Biophys Res Commun; 1986 Sep; 139(3):982-90. PubMed ID: 3533075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon.
    Tree M; Atrash B; Donovan B; Gamble J; Hallett A; Hughes M; Jones DM; Leckie B; Lever AF; Morton JJ
    J Hypertens; 1983 Dec; 1(4):399-403. PubMed ID: 6398331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New human renin inhibitory peptides: angiotensinogen transition-state analogues containing novel Leu-Val replacement and a retro-inverso amide bond.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Shimaoka I; Umeyama H; Kiso Y
    Chem Pharm Bull (Tokyo); 1988 Jun; 36(6):2278-81. PubMed ID: 3071424
    [No Abstract]   [Full Text] [Related]  

  • 19. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes.
    Foundling SI; Cooper J; Watson FE; Cleasby A; Pearl LH; Sibanda BL; Hemmings A; Wood SP; Blundell TL; Valler MJ
    Nature; 1987 May 28-Jun 3; 327(6120):349-52. PubMed ID: 3295561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of human angiotensinogen (1-17) containing one of the putative glycosylation binding sites and its hydrolysis by human renin and porcine pepsin.
    Hirata IY; Boschcov P; Oliveira MC; Juliano MA; Miranda A; Chagas JR; Tsuboi S; Okada Y; Juliano L
    Int J Pept Protein Res; 1991 Oct; 38(4):298-307. PubMed ID: 1797705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.